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A B S T R A C T
Two new series as azosalicylic acid derivatives IVa-l and Va-c in addition to three series con-
taining 8-quinolyloxy moiety Xa-i, XIIa-n and XIVa-e were synthesized for evaluation as
antimicrobial compounds. Structures of the newly synthesized compounds have been deduced
on the basis of elemental analysis and spectral data. Antimicrobial activity evaluation was
carried using agar dilution technique; there was variability in the susceptibilities of the dif-
ferent organisms to the tested compounds. Staphylococcus aureus was the most resistant
organism while Candida albicans was the most sensitive. Some compounds showed both an-
tibacterial and antifungal activity, while others showed antibacterial activity with no antifungal
activity and vice versa. Compound XIVe was the most active against both bacteria and fungi,
while compounds Xe, XIIf, XIVa and XIVd showed a moderate activity.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
There is still an increasing need for identification of novel struc-
ture leads that may be of use in designing new, potent and less
toxic antimicrobial agents due to the increase in resistance to
the available antimicrobial drugs.The previous literature survey
revealed that compounds containing p-aminobenzoic acid ester
(Prasad et al., 2012) or hydrazide moieties (Somashekhar et al.,
2013) were documented to have antimicrobial activity. Also,
several hydrazones (Kucukguzel et al., 1999) and azomethine
derivatives (Pahontu et al., 2015) of benzocaine showed a sig-
nificant antimicrobial activity. At the same time,many salicylic
acid derivatives were reported to have strong antimicrobial ac-
tivity (Yiase et al., 2014). In view of these observations and in
continuation of our previous work (Abdellatif et al., 2014), certain
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azo compounds IVa-l and Va-c having some of the above
pharmacophoric moieties were synthesized with the aim that
the products may show better antimicrobial activity.
On the other hand, compounds having both quinoline and
benzocaine moieties demonstrated a significant microbicidal
activity (Khandarkar et al., 2013). The presence of halo-
substituted aromatic residues in heterocyclic antifungal drugs
was found to be very important for its activity (Baseer et al.,
2011). Also, the presence of 5-nitro group in nitrofuran deriva-
tives was indicated to be required for antibacterial activity
(Emami et al., 2013). Moreover, the remarkable antibacterial ac-
tivity of some nitrogenous heterocycles containing terminal
acetamido groups was attributed to the increased lipophilicity
of these compounds, which facilitate its penetration into the
bacterial and fungal cells (Shams et al., 2011). This encour-
aged us to synthesize a number of derivatives Xa-i and XIIa-n
having in common 8-quinolyloxy moiety.
Additionally, quinoline compounds having sulfonamide
moiety showed a significant microbicidal activity (Srivatava and
Kumar, 2013). Based on these facts, a number of target com-
pounds XIVa-e were synthesized having a combination of
sulfonamide group together with the pharmacophoric 8-quinolyl
acetate moiety.
2. Experimental
2.1. Chemistry
2.1.1. General
Melting points were determined on a Griffin apparatus and are
uncorrected. Infrared (IR) spectra were recorded on a Shimadzu
435 Spectrometer using KBr discs and values were repre-
sented in cm−1. 1H NMR spectra were measured on a Varian
Gemini 300 MHz spectrometer in CDCl3 or DMSO-d6 with TMS
as the internal standard. Mass spectra were run on Hewlett
Packard 5988 spectrometer. Microanalyses were performed for
C, H, N (Micro Analytical Centre, Cairo University, Egypt) and
were within ±0.4% of theoretical values. Progress of the reac-
tions was monitored by TLC using TLC sheets precoated with
UV fluorescent silica gel MERCK 60 F 254 that was visualized
by UV lamp. 5-(4-Ethoxycarbonylphenylazo)-2-hydroxybenzoic
acid (II) (Raicharan and Guha, 1955), (quinol-8-yloxy)-acetic acid
(VI) (Kidwai et al., 2000), quinol-8-yloxy sodium salt (VII)
(Chandrasekhare and Bhat, 1995), ethyl (quinol-8-yloxy) acetate
(VIII) (Rabhofer et al., 1979), (quinol-8-yloxy)-acetic acid hy-
drazide (IX) (Soliman and Hammouda, 1979), N-aryl-2-
chloroacetamides XIa-n (El-Moghazy, 1992), and (quinol-8-yl)
α-chloroacetate (XIII) (El-zohry et al., 1992) were prepared ac-
cording to reported procedures.
2.1.2. 5-(4-Hydrazinocarbonylphenylazo)-2-hydroxybenzoic
acid (III)
Amixture of 5-(4-ethoxycarbonylphenylazo)-2-hydroxybenzoic
acid (II) (3.14 g, 0.01 mole) and hydrazine hydrate (99%, 0.01
mole) in absolute ethanol (50 mL) was heated under reflux for
6 hours. After cooling to room temperature, the separated solid
was filtered and then dried. Crystallization of the product from
ethanol afforded the title compound III as dark orange-red crys-
tals. m.p. 230–2 °C,Yield : 2.04 g, 68%; IR (cm−1) 3316, 3166 (NH2),
3448–2833 (OH of COOH, OH phenolic, NH amidic, CH str. aro-
matic), 1712 (C=O of COOH), 1686 (C=O amidic), 1606 (N=N),
1529 (C=C aromatic); 1H NMR (DMSO-d6) δ 4.24–4.37 (m, 3H, OH,
NH2, D2O exchangeable), 7.70–7.75 (d, 2H, H3, H4 of salicyl group),
7.82 (s, 1H, NH, D2O exchangeable), 7.88–7.91 (d, 2H, Hb of
p-phenylenemoiety), 8.09–8.13 (d, 2H, Ha of p-phenylenemoiety),
8.30 (s, 1H, H6 of salicyl group), 10.40 (s, 1H, COOH, D2O ex-
changeable); EIMS 300 (M+). Anal. calcd for C14H12N4O4: C, 56.00;
H, 4.03; N, 18.66. Found: C, 56.34; H, 4.25; N, 18.37.
2.1.3. General procedure for synthesis of
5-[4-(N2-arylidenehydrazinocarbonyl)phenylazo]-2-hydro-
xybenzoic acids (IVa-l)
To a solution of 5-(4-hydrazinocarbonylphenylazo)-2-
hydroxybenzoic acid (III) (0.6 g, 0.002 mole) in absolute ethanol
(20 mL), the appropriate aromatic carbonyl compound (0.002
mole) was added and the mixture was heated under reflux for
2 hours. After cooling to room temperature, the separated solid
was filtered, washed with ethanol and crystallized from the
suitable solvent. Physical and elemental analyses data for com-
pounds IVa-l are listed in Table 1. Spectral data are listed below:
IR (KBr), ν cm-1 for IVa-l: 3500–2500 (OH phenolic, NH, COOH),
1680–1660 (C=O of COOH), 1660–1640 (C=O amidic), 1640–
1620 (C=N), 1610–1590 (N=N).
1H NMR (DMSO, δ ppm) for IVd: 6.83–6.93 (d, 2H, H3, H5 of
p-hydroxybenzylidene moiety), 7.12–7.15 (d, 2H, Hb of
p-phenylene moiety), 7.65 (s, 1H, CH=N), 7.71 (s, 1H, OH,
D2O exchangeable), 7.72–7.76 (d, 2H, H3, H4 of salicyl
group), 7.90–7.94 (d, 2H, Ha of p-phenylene moiety), 8.05
(s, 1H, OH, D2O exchangeable), 8.06–8.12 (d, 2H, H2, H6 of
p-hydroxybenzylidene moiety), 8.34 (s, 1H, NH, D2O ex-
changeable), 8.53 (s, 1H, H6 of salicyl group), 9.76 (s, 1H, COOH,
D2O exchangeable).
1H NMR (DMSO, δ ppm) for IVg: 7.28 (s, 1H, CH=N), 7.36–
7.52 (m, 5H, 4H aromatic protons, NH, D2O exchangeable),
7.72–7.92 (m, 7H, 6 aromatic protons, OH, D2O exchange-
able), 8.52–8.62 (m, 2H, 1 aromatic proton, COOH, D2O
exchangeable).
2.1.4. General procedure for synthesis of 2-hydroxy-5-(4-
substituted-phenylazo)benzoic acid derivatives (Va-c)
To a solution of 5-(4-hydrazinocarbonylphenylazo)-2-
hydroxybenzoic acid (III) (1.5 g, 0.005 mole) in glacial acetic acid
(20 mL), the appropriate acid anhydride (0.005 mole) was added
and the mixture was heated under reflux for 5 hours. After
cooling, the reactionmixture was poured onto crushed ice (30 g).
The precipitated solid was filtered, washed with water and crys-
tallized from the appropriate solvent. Physical and elemental
analyses data for compounds Va-c are listed in Table 2. Spec-
tral data are listed below:
IR (KBr), ν cm−1 for Va-c: 3350–2740 (NH amidic, OH pheno-
lic, COOH, CH str. aromatic), 1715 (C=O of COOH), 1680, 1663,
1603 (three amidic C=O), 1560 (N=N).
1H NMR (DMSO, δ ppm) forVc: 3.68 (s, 1H, NH, D2O exchange-
able), 4.33 (s, 1H, OH, D2O exchangeable), 7.85–7.90 (m, 3H,
aromatic protons), 7.92–7.95 (d, 2H, Hb of p-phenylene
moiety), 8.05–8.09 (m, 3H, aromatic protons), 8.11–8.14
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(d, 2H, Ha of p-phenylene moiety), 8.36 (s, 1H, H6 of salicyl
group), 10.22 (s, 1H, COOH, D2O exchangeable).
2.1.5. General procedure for synthesis of (quinol-8-yloxy)-
acetic acid (N2-arylidene) hydrazides (Xa-i)
To a solution of (quinol-8-yloxy)-acetic acid hydrazide (IX) (0.002
mole) in absolute ethanol (20 mL), the appropriate aromatic al-
dehyde (0.002 mol) was added and the mixture was heated
under reflux for 2 hours. On cooling, the separated solid was
filtered, dried and crystallized from the suitable solvent. Physi-
cal and elemental analyses data for compounds Xa-i are listed
in Table 3. Spectral data are listed below:
IR(KBr, ν cm−1) for Xa-I: 3500–3400 NH and (OH in Xa), 3100–
3000 (CH str. aromatic), 3000–2900 (CH str. aliphatic), 1650–
1630 (C=O), 1610–1590 (C=N), 1200 (C—O—C).
Table 1 – Physical and elemental analyses data for compounds IVa-l.
IV R1 R2 mp.(°C)/Crystal
color
Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses %
Calcd. Found
a CH3 H 105–7/reddish brown Methanol 61 C22H18N4O4
(402.41)
C 65.66 65.58
H 4.51 4.84
N 13.92 14.25
b H o-OH 204–6/orange Ethanol 69 C21H16N4O5
(404.38)
C 62.37 62.09
H 3.99 4.01
N 13.85 13.72
c H m-OH 140–2/yellow Ethanol 66 C21H16N4O5
(404.38)
C 62.37 62.61
H 3.99 3.82
N 13.85 13.75
d H p-OH 156–8/red Methanol 63 C21H16N4O5
(404.38)
C 62.37 62.48
H 3.99 4.00
N 13.85 13.76
e H o-Cl 139–41/yellowish orange Ethanol 70 C21H15CIN4O4
(422.83)
C 59.65 59.46
H 3.58 3.44
N 13.25 13.55
f H m-Cl 136–8/light yellow Ethanol 68 C21H15CIN4O4
(422.83)
C 59.65 60.01
H 3.58 3.76
N 13.25 12.97
g H p-Cl 200–2/yellow Ethanol 65 C21H15CIN4O4
(422.83)
C 59.65 59.89
H 3.58 3.68
N 13.25 13.56
h H p-N(CH3)2 285–7/red Ethanol 73 C23H21N5O4
(431.45)
C 64.03 64.06
H 4.91 5.00
N 16.23 16.54
i H o-NO2 275–7/orange Ethanol 73 C21H15N5O6
(433.38)
C 58.20 57.86
H 3.49 3.20
N 16.16 16.16
j H m-NO2 180–2/yellowish orange Methanol 63 C21H15N5O6
(433.38)
C 58.20 57.88
H 3.49 3.35
N 16.16 15.86
k H p-NO2 280–2/light yellow Ethanol 75 C21H15N5O6
(433.38)
C 58.20 58.31
H 3.49 3.86
N 16.16 16.14
l H o-Br 160–2/yellow Benzene 72 C21H15BrN4O4
(467.28)
C 53.98 53.63
H 3.24 3.22
N 11.99 11.69
Table 2 – Physical and elemental analyses data for compounds Va-c.
V mp.(°C) Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses %
Calcd. Found
a 185–7 Aq. ethanol 65 C18H12N4O6
(380.32)
C 56.85 56.90
H 3.18 3.50
N 14.73 14.52
b 198–200 ethanol 61 C18H14N4O6
(382.33)
C 56.55 56.60
H 3.69 3.60
N 14.65 14.56
c 270–2 methanol 74 C22H14N4O6
(430.38)
C 61.40 61.65
H 3.28 3.52
N 13.02 12.96
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1H NMR (DMSO, δ ppm) for Xd: 3.31 (s, 2H, CH2), 4.95 (s, 1H,
CH=N), 5.30 (s, 1H, NH, D2O exchangeable), 7.48–7.80 (m, 3H,
H5, H6, H7 of quinolyl group), 8.04–8.16 (m, 2H, H4, H6 of
o-nitrobenzylidene moiety), 8.30–8.33 (d, 1H, H3 of quinolyl
group), 8.37–8.4 (d, 1H, H5 of o-nitrobenzylidenemoiety), 8.72–
8.78 (d, 1H, H4 of quinolyl group), 8.82–8.86 (d, 1H, H3 of
o-nitrobenzylidene moiety), 8.89–8.95 (d, 1H, H2 of quinolyl
group).
2.1.6. General procedure for synthesis of N-Aryl-2-(quinol-8-
yloxy) acetamides (XIIa-n)
Amixture of the respectiveN-aryl-2-chloroacetamide XIa-n (0.01
mole), 8-quinoloxy sodium salt (VII) (1.67 g, 0.01 mole) and po-
tassium carbonate (1.38 g, 0.01 mole) in dry dimethylformamide
(15 mL) was heated at 100 °C for 3 hours. After cooling, the re-
action mixture was poured onto crushed ice (20 g). The
precipitated solid was filtered, washed with water, dried and
crystallized from the suitable solvent. Physical and elemen-
tal analyses data for compounds XIIa-n are listed in Tables 4
and 5. Spectral data are listed below:
IR (KBr, ν cm−1) for XIIa-n: 3490–3270 NH and (COOH of XIIk),
3016 (CH str. aromatic), 2920 (CH str. aliphatic), 1713 (C=O
of COOH in XIIk), 1708 (C=O of COOC2H5 in XIIn), 1690–
1665 (C=O amidic), 1620 (C=O of COCH3 in XIIj).
1H NMR (CDCl3, δ ppm) for XIId: 2.14 (s, 6H, 2 CH3), 5.02 (s,
2H, OCH2), 7.04–7.14 (m, 3H, H5, H6, H7 of quinolyl group), 7.27–
7.33 (m, 2H, H3, H5 of dimethylphenyl group), 7.46–7.50 (m,
1H, H4 of dimethylphenyl group), 7.52–7.56 (m, 1H, H3 of
quinolyl group), 8.20–8.23 (dd, 1H, H4 of quinolyl group), 8.87–
8.89 (dd, 1H, H2 of quinolyl group), 9.45 (s, 1H, NH, D2O
exchangeable).
1H NMR (CDCl3, δ ppm) for XIIi: 4.9 (s, 2H, O—CH2), 7.08–7.12
(d, 1H, H5 of m-chlorophenyl moiety), 7.23–7.31 (m, 4H, H3,
H5, H6, H7 of quinolyl group), 7.51–7.66 (m, 2H, H4, H6 of
m-chlorophenyl moiety), 7.85 (s, 1H, H2 of m-chlorophenyl
moiety), 8.23–8.27 (d, 1H, H4 of quinolyl group), 8.97–8.99 (d,
1H, H2 of quinolyl group), 9.81 (s, 1H, NH, D2O exchangeable).
2.1.7. General procedure for synthesis of quinol-8-yl [4-
(arylsulfamoyl)-phenyl]-aminoacetate (XIVa-e)
To a mixture of 8-quinolyl α-chloroacetate (XIII) (1.1 g, 0.005
mole) and anhydrous potassium carbonate (0.69 g, 0.005 mole)
in dry acetone (15mL), the appropriate sulfonamide (0.005mole)
was added.The reaction mixture was then heated under reflux
for 24 hours. After cooling to room temperature, the mixture
was filtered and the filtrate was evaporated under reduced pres-
sure and the crude product was crystallized from the suitable
solvent to afford XIVa-e. Physical and elemental analyses data
for compounds XIVa-e are listed in Table 6. Spectral data are
listed below:
IR (KBr, ν cm−1) for XIVa-e: 3500–3200 (2 NH) and (NH2 of XIVa,
c and NH of imine moiety in XIVc), 1660 (C=O of COCH3 in
XIVb), 1650–1600 (C=O of ester moiety), 1530 (C=N in XIVc),
1336, 1152 (S=O of SO2).
1H NMR (DMSO, δ ppm) for XIVa: 3.45 (s, 2H, CH2), 5.86 (s, 1H,
NH, D2O exchangeable), 7.08–7.13 (d, 2H, Hb of p-phenylene
moiety), 7.36–7.56 (m, 6H, H3, H5, H6, H7 of quinolyl group,
2Ha of p-phenylene moiety), 8.28–8.33 (d, 1H, H4 of quinolyl
Table 3 – Physical and elemental analyses data for compounds Xa-i.
X R mp.(°C) Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses%
Calcd. Found
a p-OH 198–8 Methanol 62 C18H15N3O3
(321.34)
C 67.28 67.10
H 4.71 4.39
N 13.08 13.00
b o-Cl 142–4 Ethanol 70 C18H14CIN3O2
(339.78)
C 63.63 63.30
H 4.15 4.19
N 12.37 12.51
c m-Cl 110–1 Ethanol 54 C18H14CIN3O2
(339.78)
C 63.63 63.30
H 4.15 4.23
N 12.37 11.94
d o-NO2 170–1 Ethanol 64 C18H14N4O4
(350.33)
C 61.71 62.09
H 4.03 4.01
N 15.99 16.10
e m-NO2 207–9 Ethanol 60 C18H14N4O4
(350.33)
C 61.71 61.50
H 4.03 4.22
N 15.99 15.72
f p-NO2 306–8 Methanol 81 C18H14N4O4
(350.33)
C 61.71 61.69
H 4.03 4.35
N 15.99 16.31
g o-Br 170–2 Benzene 74 C18H14BrN3O2
(384.23)
C 56.27 56.60
H 3.67 3.51
N 10.94 11.24
h m-Br 158–60 Ethanol 76 C18H14BrN3O2
(384.23)
C 56.27 56.81
H 3.67 3.60
N 10.94 10.89
i p-Br 207–8 Benzene 70 C18H14BrN3O2
(384.23)
C 56.27 56.30
H 3.67 3.20
N 10.94 10.91
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Table 4 – Physical and elemental analyses data for compounds XIIa-f.
XII Ar mp.(°C) Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses %
Calcd. Found
a 95–6 Ethanol 66 C18H16N2O2
(292.34)
C 73.95 73.66
H 5.52 6.00
N 9.58 9.57
b 103–5 Ethanol 53 C18H16N2O2
(292.34)
C 73.95 73.86
H 5.52 5.70
N 9.58 9.52
c 99–100 Ethanol 64 C18H16N2O2
(292.34)
C 73.95 73.66
H 5.52 5.70
N 9.58 9.46
d 197–9 Aq. ethanol 55 C19H18N2O2
(306.37)
C 74.49 74.20
H 5.92 6.00
N 9.14 9.12
e 109–11 Aq. ethanol 52 C18H16N2O3
(308.34)
C 70.12 69.90
H 5.23 5.20
N 9.09 8.80
f 106–8 Aq. ethanol 59 C18H16N2O3
(308.34)
C 70.12 69.88
H 5.23 5.38
N 9.09 9.03
Table 5 – Physical and elemental analyses data for compounds XIIg-n.
XII Ar mp.(°C) Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses %
Calcd. Found
g 114–6 Aq. ethanol 66 C18H16N2O3
(308.34)
C 70.12 69.94
H 5.23 5.05
N 9.09 8.93
h 178–9 Methanol 62 C17H13CIN2O2
(312.76)
C 65.29 65.08
H 4.19 4.37
N 8.96 8.89
i 197–9 Ethanol 57 C17H13CIN2O2
(312.76)
C 65.29 65.00
H 4.19 4.03
N 8.96 8.91
j 110–2 n-Hexane 70 C19H16N2O3
(320.35)
C 71.24 70.97
H 5.03 4.61
N 8.74 8.68
k >300 Ethanol 45 C18H14N2O4
(322.32)
C 67.08 66.76
H 4.38 4.59
N 8.69 8.70
l 196–8 Ethanol 68 C17H13N3O4
(323.31)
C 63.16 63.30
H 4.05 4.23
N 12.99 12.86
m 274–5 n-Hexane 72 C21H16N2O2
(328.37)
C 76.81 76.60
H 4.91 5.00
N 8.53 8.58
n 117–9 Aq. ethanol 74 C20H18N2O4
(350.38)
C 68.56 68.37
H 5.18 4.87
N 7.99 8.05
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Table 6 – Physical and elemental analyses data for compounds XIVa-e.
XIV R mp.(°C) Cryst.
solvent
Yield
(%)
Mol. form.
(mol. wt.)
Analyses %
Calcd. Found
a H 137–9 Ethanol 61 C17H15N3O4S
(357.38)
C 57.13 57.60
H 4.23 4.20
N 11.76 11.50
b COCH3 207–9 Ethanol 55 C19H17N3O5S
(399.43)
C 57.13 57.60
H 4.29 4.20
N 10.52 10.32
c 146–8 Methanol 59 C18H17N5O4S
(399.43)
C 54.13 54.60
H 4.29 4.40
N 17.53 17.55
d 240–2 Ethanol 64 C21H17N5O4S
(435.47)
C 57.92 58.00
H 3.94 4.00
N 16.08 16.58
e 245–7 Methanol 57 C23H21N5O4S
(463.52)
C 59.60 59.79
H 4.57 4.27
N 15.11 14.99
Scheme 1 – Synthetic protocol for compounds IVa-l and Va-c.
152 b en i - s u e f un i v e r s i t y j o u rna l o f b a s i c and a p p l i e d s c i e n c e s 5 ( 2 0 1 6 ) 1 4 7 – 1 5 5
group), 8.82–8.85 (d, 1H, H2 of quinolyl group), 9.87 (s, 2H,
NH2, D2O exchangeable).
2.2. Antimicrobial evaluation
The antimicrobial activity was determined using the agar di-
lution technique using ofloxacin and clotrimazole as positive
controls and the solvent, dimethylformamide (DMF), as a nega-
tive control according to a previously reported procedure (Hewitt
and Vincet, 1989).
3. Results and discussion
3.1. Chemistry
5-(4-Ethoxycarbonylphenylazo)-2-hydroxybenzoic acid (II) was
prepared from benzocaine (I) in two steps according to a re-
ported procedure (Raicharan and Guha, 1955). Reacting II with
hydrazine hydrate yielded the corresponding hydrazide III in
68% yield, which upon reaction with the appropriate aromatic
carbonyl compound under reflux condition gave 5-[4-(N2-
arylidenehydrazino-carbonyl)phenylazo]-2-hydroxybenzoic
acids (IVa-l) in good yields (61–75%). Also, reacting 5-(4-
hydrazinocarbonylphenylazo)-2-hydroxybenzoic acid (III) with
maleic,succinicorphthalic anhydride inglacial acetic acidyielded
the corresponding substituted amides (Va-c) (Scheme 1).
Furthermore, ethyl (quinol-8-yloxy)-acetate (VIII) was pre-
pared as a precursor to the hydrazide IX. Condensation of the
latter with a number of aromatic aldehydes led to the
azomethine derivatives Xa-i in moderate yield (54%) to high
yield (81%). The precursor ester VIII was obtained via two
methods starting either from the corresponding acid VI or from
quinolyloxy sodium salt VII (Scheme 2).
Scheme 2 – Synthetic protocol for compounds Xa-i.
Scheme 3 – Synthetic protocol for compounds XIIa-n.
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Also, the target amides XIIa-n were successfully synthe-
sized via reacting α-chloroacetamides XIa-n with quinol-8-
yloxy sodium salt (VII) in dimethylformamide with catalytic
amount of anhydrous K2CO3 (Scheme 3).
Moreover, reaction of (quinol-8-yl) α-chloroacetate (XIII) with
different sulfonamides in dry acetone using catalytic amounts
of anhydrous K2CO3 gave the target compounds quinol-8-yl [4-
(arylsulfamoyl)-phenyl]-aminoacetates (XIVa-e) (Scheme 4).
3.2. Pharmacological screening
The antimicrobial activity of twenty representative com-
pounds was studied using the agar dilution technique using
ofloxacin and clotrimazole as positive controls and the solvent,
dimethylformamide (DMF), as a negative control. The synthe-
sized compounds were screened for their in vitro antimicrobial
testing using five selected standard isolates as a representa-
tive examples of different types of microorganisms as follows:
gram-positive both non-sporulated bacteria as Staphylococcus
aureus, sporulated as Bacillus subtilis, gram-negative bacteria both
sensitive as Escherichia coli, resistant as Pseudomonas aeruginosa
and a fungus as Candida albicans. The results are recorded in
Table 7 and it was clear that there is variability in the suscep-
tibilities of the different organisms to the different compounds.
Staphylococcus aureus was the most resistant organism while
Candida albicans was the most sensitive. Some compounds
showed both antibacterial and antifungal activity, while others
showed antibacterial activity with no antifungal activity and
vice versa. Compound XIVe was the most active against both
bacteria and fungi, while compounds Xe, XIIf, XIVa and XIVd
showed a moderate activity.
4. Conclusion
It can be concluded that the combination of 8-quinolyl acetate
moiety with compounds having sulfonamide moiety gives a
significant antimicrobial activity as shown for compounds XIVa,
XIVd and XIVe.
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